FHA
WST icon

Flagship Harbor Advisors’s West Pharmaceutical WST Stock Holding History

Flagship Harbor Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$359K Sell
1,000
-50
-5% -$15.3K 0.01% 593
2026
Q1 		$263K Buy
1,050
+50
+5% +$12.4K 0.01% 633
2025
Q4 		$275K Sell
1,000
-91
-8% -$24.9K 0.01% 586
2025
Q3 		$286K Buy
1,091
+39
+4% +$9.48K 0.01% 646
2025
Q2 		$230K Buy
1,052
+26
+3% +$5.56K 0.01% 686
2025
Q1 		$230K Buy
+1,026
New +$283K 0.01% 669
2024
Q4 		– Sell
-795
Closed -$239K – 792
2024
Q3 		$239K Sell
795
-95
-11% -$29.1K 0.01% 634
2024
Q2 		$293K Sell
890
-119
-12% -$42.1K 0.02% 546
2024
Q1 		$399K Buy
1,009
+327
+48% +$121K 0.03% 440
2023
Q4 		$240K Sell
682
-13
-2% -$4.6K 0.02% 547
2023
Q3 		$261K Hold
695
– – 0.02% 511
2023
Q2 		$266K Sell
695
-1,825
-72% -$652K 0.02% 506
2023
Q1 		$873K Buy
+2,520
New +$736K 0.08% 239
2022
Q3 		– Sell
-720
Closed -$218K – 626
2022
Q2 		$218K Sell
720
-33
-4% -$10.7K 0.02% 544
2022
Q1 		$309K Sell
753
-456
-38% -$179K 0.03% 473
2021
Q4 		$567K Sell
1,209
-4
-0.3% -$1.72K 0.05% 334
2021
Q3 		$436K Hold
1,213
– – 0.05% 374
2021
Q2 		$436K Sell
1,213
-10
-0.8% -$3.3K 0.05% 375
2021
Q1 		$345K Buy
1,223
+163
+15% +$46.6K 0.04% 439
2020
Q4 		$300K Buy
1,060
+2
+0.2% +$561 0.04% 429
2020
Q3 		$290K Buy
1,058
+774
+273% +$205K 0.04% 375
2020
Q2 		$64K Buy
+284
New +$55.8K 0.01% 783
2018
Q4 		– Sell
-163
Closed -$20K – 2118
2018
Q3 		$20K Sell
163
-78
-32% -$8.75K ﹤0.01% 1122
2018
Q2 		$23K Buy
+241
New +$22.2K ﹤0.01% 1056

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Flagship Harbor Advisors's WST Position: Q2 2026 in Review

Flagship Harbor Advisors reduced its West Pharmaceutical (WST) stake by 4.8% in Q2 2026, selling an estimated $15.3K and leaving 1,000 shares worth $359K. The position accounts for 0.01% of the portfolio, ranked #593.

Flagship Harbor Advisors first reported a position in WST in Q2 2018 and has held it in 24 quarters since. The position peaked at $873K in Q1 2023. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Flagship Harbor Advisors held 1,000 shares of West Pharmaceutical worth $359K as of Q2 2026.
  • Flagship Harbor Advisors sold 50 West Pharmaceutical shares in Q2 2026, an estimated $15.3K.
  • West Pharmaceutical made up 0.01% of Flagship Harbor Advisors's portfolio in Q2 2026, its #593 holding.
  • Flagship Harbor Advisors first reported a position in West Pharmaceutical in Q2 2018 and has held it in 24 quarters since.
  • Flagship Harbor Advisors's West Pharmaceutical position peaked at $873K in Q1 2023.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Flagship Harbor Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.